# PLATON (NCT03784755)

> Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03784755
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Canadian Cancer Trials Group
- Conditions: Prostate Cancer Metastatic
- Interventions: Ablative Radiation Therapy; Standard of care
- Enrollment: 409
- Primary outcome: Failure-free Survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 2
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=platon-nct03784755